Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia

Li Yu(Jiangnan University), Yi Ning(University of Maryland, Baltimore), C Lee(Brigham and Women's Hospital), Ivana Gojo(Johns Hopkins University), Maria R. Baer(University of Maryland, Baltimore), Jiang Ha(Brigham and Women's Hospital), X. Frank Zhao(University of Maryland, Baltimore), C Chen(University of Maryland, Baltimore), Teresa York(University of Maryland, Baltimore), Jocelyn Reader(University of Maryland, Baltimore)
Leukemia
December 10, 2010
10.1038/leu.2010.271
Cited by 35

Related Papers

Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
<i>IDH1</i> and <i>IDH2</i> Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
|Journal of Clinical Oncology|2010|764
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study
|The Lancet Oncology|2017|493